Pharmafile Logo
Pharmafocus logo
Advanced Search

market access

Showing 15 posts of 52 posts found.

Partnership with payers: Communicating and negotiating with impact

December 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, market access, pharma

NDA’s Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising team …

News

Redefining the value of medicines with patients at the centre

November 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, health economics and outcomes research, market access, pharma

Liz Lewis, Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology, discusses the importance and challenges of …

Feature
shutterstock_57369385

Epilepsy Society calls for review of UK supply chain following “steep rise” in access issues

April 9, 2019
Manufacturing and Production, Sales and Marketing Epilepsy Society, UK, brexit, epilepsy, market access, pharma

The Epilepsy Society has drawn attention to the “steep rise” in UK patients who are encountering difficulty in accessing seizure …

News
pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …

News
pharmafocus_june_2018_cover

The June 2018 issue of Pharmafocus is now live!

May 31, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma

The new June edition of Pharmafocus is now available to read online.

News
brexit-referendum-uk-1468255193y2p

Brexit Health Alliance: Brexit and the impact on patient access to medicines

March 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …

Feature

FDA access programmes shaved up to a year off drug approval times, new study shows

December 7, 2017
Research and Development, Sales and Marketing FDA, market access, pharma

A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could …

News
shutterstock_57369385

Refining the system: Improving patients’ access to medicine

September 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

Feature
europe-1395916_640

New game, new rules: Pathways for better and affordable medicines in Europe

June 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …

Feature
pharmafocus_june_2017_cover

The June 2017 issue of Pharmafocus is now live!

May 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders

The latest edition of Pharmafocus is available to read online now!

News
2000px-flag_of_pakistan

Novartis signs drug access deal with Pakistan government

May 12, 2017
Medical Communications, Sales and Marketing Islamabad, Novartis, Pakistan, market access

Pakistan’s Ministry of National Health Services, Regulations and Coordination has signed an agreement with Novartis to improve access to medicines …

News
business

2016 Top markets report

December 23, 2016
Medical Communications market, market access

2016 Top Markets Report

News
gsk_wall

GSK emerges top of the pile for improving access to medicine

November 14, 2016
Medical Communications, Sales and Marketing Access to Medicine Index, GSK, market access, pricing

GlaxoSmithKline, the British drugmaker, has topped the overall ranking of the Access to Medicine Index, which ranks 20 top pharmaceutical …

News

Nice extends price-negotiation talks for PTC’ muscle wasting drug

May 4, 2016
Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, NICE, PTC Therapeutics, Translarna, market access, regulation

UK regulators have extended the cost negotiation talks with PTC Therapeutics (Nasdaq: PTCT) by a week for the drug to …

News
cdic_bangladesh_dhaka_day_12

Two billion people still lack medicines access. Is the industry doing enough?

December 22, 2015
Manufacturing and Production Access to Medicine Foundation, Access to Medicine Index, affordability, market access, medicines access, pricing

“We have a mission to encourage the pharmaceutical industry in improving access to medicine for the two billion people who …

Feature

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024